Edward Esposito has a strong background in biophysics and analytical method development. Edward is currently working as a Principal Scientist in Biophysics at Beam Therapeutics. Prior to that, they held roles as a Principal Scientist at GreenLight Biosciences and as a Principal Application Development Scientist at Malvern Panalytical. Edward also has experience as a Laboratory Test Engineer at GE Healthcare and as the Head of Assay Services at Blue Sky BioServices. Edward Esposito is also a cofounder and chief scientist at P.A. Technologies, LLC where they focused on developing biochemical assays for membrane-associated protein targets. Edward started their career in biophysical chemistry at UMass Amherst.
Edward Esposito holds a Ph.D. in Biophysical Chemistry from the University of Massachusetts Amherst. Prior to that, they earned two Bachelor of Science degrees in Chemistry and Biology from Southern Connecticut State University.
September, 2023 - present